Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
A new proposal suggests spreading drug development risk among many small investors.
By Ed Anderson
There's no way around it. Obtaining approval to market a new drug is lengthy, complex, costly and fraught with uncertainty and risk. Financial engineers at MIT propose a strategy to minimize that risk – one that deserves a close look.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AQpKAu
Cap comentari:
Publica un comentari a l'entrada